← Leaderboards
Sumitra Deb
Virginia Commonwealth University
$2,681,956
Attributed
$4,126,208
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $474.1K · FY2008–24$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,126,208 · 4
By mechanism
R01$3,521,041 · 3
R21$605,167 · 1
Top collaborators
- Brad E. Windle7 shared
- Swati P Deb1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Brad E. Windle$1,995,833
- Swati P Deb$961,946
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantCellsProteinsGain Of FunctionCancer CellMalignant NeoplasmsTp53 GeneTumorVectorMutationPropertyAffectPhenotypeOncogenicMalignant Neoplasm Of LungLung NeoplasmsGenesLungBasePromoterNeoplasm MetastasisPathway InteractionsAllelesInhibitor/Antagonist
Grant awards (14)
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes$450,358
R01 · FY2024 · CA · contact PI
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes$464,578
R01 · FY2023 · CA · contact PI
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes$464,578
R01 · FY2022 · CA · contact PI
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes$474,061
R01 · FY2021 · CA · contact PI
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes$429,763
R01 · FY2020 · CA · contact PI
The GOF Mutant p53 Beacon System$188,241
R21 · FY2019 · CA
The GOF Mutant p53 Beacon System$193,776
R21 · FY2018 · CA
The GOF Mutant p53 Beacon System$223,150
R21 · FY2017 · CA
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer$240,725
R01 · FY2011 · CA · contact PI
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer$248,170
R01 · FY2010 · CA · contact PI
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer$30,000
R01 · FY2010 · CA · contact PI
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer$248,170
R01 · FY2009 · CA · contact PI
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer$247,478
R01 · FY2008 · CA · contact PI
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS$223,160
R01 · FY2000 · CA